HIGHLIGHTS
- who: Mycobacterium bovis et al. from the School of Biological, University of Reading, Reading, United Kingdom, The Pirbright Institute, Woking have published the research: Towards Reverse Vaccinology for Bovine TB: High Throughput Expression of Full Length Recombinant Mycobacterium bovis Proteins, in the Journal: (JOURNAL)
- what: To assess feasibility for proteins that might be targeted for vaccine use and to provide such proteins for testing the authors report a high throughput expression approach (Aricescu et_al, 2006; Nettleship et_al, 2010; Bird et_al, 2014) to the expression of many full-length Mycobacterium bovis ORFs. candidate vaccine and roles . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.